Is Alpha Teknova Inc (TKNO) overvalued? · rev $37.7M
Alpha Teknova Inc (TKNO) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page asks whether Alpha Teknova Inc (TKNO) looks expensive on cached numbers — not a short thesis.
Latest reported TKNO revenue for 2024-12-31 was $37.7M. Net income was -$26.7M. Revenue was up 2.9% from 2023-12-31 to 2024-12-31. TKNO currently screens at market cap $221.4M.
TKNO currently screens at market cap $221.4M. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next TKNO 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the TKNO stock page for the full model, not this heading.
Not investment advice.